Zhang Y - Search Results

1

Targeting Interferon Regulatory Factor for Cardiometabolic Diseases: Opportunities and Challenges.

Zhang Y, Zhang XJ, Li H. Zhang Y, et al. Among authors: zhang xj. Curr Drug Targets. 2017;18(15):1754-1778. doi: 10.2174/1389450116666150804110412. Curr Drug Targets. 2017. PMID: 26240052 Review.

2

The innate immune signaling in cancer and cardiometabolic diseases: Friends or foes?

Wang W, Zhang Y, Yang L, Li H. Wang W, et al. Among authors: zhang y. Cancer Lett. 2017 Feb 28;387:46-60. doi: 10.1016/j.canlet.2016.06.004. Epub 2016 Jun 22. Cancer Lett. 2017. PMID: 27339326 Review.

3

Reprogramming Innate Immune Signaling in Cardiometabolic Disease.

Zhang Y, Zhang XJ, Wang PX, Zhang P, Li H. Zhang Y, et al. Among authors: zhang p, zhang xj. Hypertension. 2017 May;69(5):747-760. doi: 10.1161/HYPERTENSIONAHA.116.08192. Epub 2017 Mar 20. Hypertension. 2017. PMID: 28320852 Review. No abstract available.

4

Reprogramming Interferon Regulatory Factor Signaling in Cardiometabolic Diseases.

Zhang Y, Li H. Zhang Y, et al. Physiology (Bethesda). 2017 May;32(3):210-223. doi: 10.1152/physiol.00038.2016. Physiology (Bethesda). 2017. PMID: 28404737 Free article. Review.

5

Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis.

Xiang M, Wang PX, Wang AB, Zhang XJ, Zhang Y, Zhang P, Mei FH, Chen MH, Li H. Xiang M, et al. Among authors: zhang p, zhang xj, zhang y. J Hepatol. 2016 Jun;64(6):1365-77. doi: 10.1016/j.jhep.2016.02.002. Epub 2016 Feb 6. J Hepatol. 2016. PMID: 26860405

6

Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis.

Gao L, Wang PX, Zhang Y, Yu CJ, Ji Y, Wang X, Zhang P, Jiang X, Jin H, Huang Z, Zhang ZR, Li H. Gao L, et al. Among authors: zhang p, zhang zr, zhang y. J Hepatol. 2016 Jul;65(1):125-136. doi: 10.1016/j.jhep.2016.03.006. Epub 2016 Mar 23. J Hepatol. 2016. PMID: 27032381

7

Insights into innate immune signalling in controlling cardiac remodelling.

Zhang Y, Huang Z, Li H. Zhang Y, et al. Cardiovasc Res. 2017 Nov 1;113(13):1538-1550. doi: 10.1093/cvr/cvx130. Cardiovasc Res. 2017. PMID: 29088374 Review.

8

LILRB4 deficiency aggravates the development of atherosclerosis and plaque instability by increasing the macrophage inflammatory response via NF-κB signaling.

Jiang Z, Qin JJ, Zhang Y, Cheng WL, Ji YX, Gong FH, Zhu XY, Zhang Y, She ZG, Huang Z, Li H. Jiang Z, et al. Among authors: zhang y. Clin Sci (Lond). 2017 Sep;131(17):2275-2288. doi: 10.1042/CS20170198. Epub 2017 Jul 25. Clin Sci (Lond). 2017. PMID: 28743735

9

Distribution of opioid analgesics by community racial/ethnic and socioeconomic profiles, 2011-2021.

Hu JC, Chakraborty P, Zhang H, Portenoy R, Rosa WE, Zhang Y, Reid MC, Tamimi RM, Zhang F, Bruera E, Paice JA, Bao Y. Hu JC, et al. Among authors: zhang y. Pain. 2025 Jan 21. doi: 10.1097/j.pain.0000000000003511. Online ahead of print. Pain. 2025. PMID: 39847449

10

Fully Atomistic Molecular Dynamics Simulation of Ice Nucleation Near an Antifreeze Protein.

Zhang Y, Wei N, Li L, Liu Y, Huang C, Li Z, Huang Y, Zhang D, Francisco JS, Zhao J, Wang C, Zeng XC. Zhang Y, et al. J Am Chem Soc. 2025 Jan 23. doi: 10.1021/jacs.4c15210. Online ahead of print. J Am Chem Soc. 2025. PMID: 39847391

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262,526 results

Search Page

Filters